Skip to main content
Intrasense logo

Intrasense — Investor Relations & Filings

Ticker · ALINS ISIN · FR0011179886 LEI · 969500VF6MOVQXWHAE33 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 310 across all filing types
Latest filing 2021-09-27 Regulatory Filings
Country FR France
Listing PA ALINS

About Intrasense

https://www.intrasense.fr/

Intrasense, a subsidiary of the Guerbet Group, is a medical technology company that develops and markets advanced software solutions for medical imaging. Its flagship product, the Myrian® platform, is a comprehensive visualization tool that assists healthcare professionals in reviewing and analyzing 2D and 3D medical images from modalities such as MRI and CT scanners. The company's solutions are characterized by the native integration of Artificial Intelligence (AI) algorithms to enhance diagnostic accuracy and workflow efficiency. Intrasense also offers specialized solutions, including Liflow® for oncology imaging and the DUOnco™ suite of AI tools for lesion detection. The technology aims to facilitate and secure clinical diagnosis, decision-making, and therapeutic monitoring for radiologists and other clinicians.

Recent filings

Filing Released Lang Actions
Lauréat des Trophées de la e-santé 2021 : Intrasense remporte le 1er prix de la catégorie Covid-19
Regulatory Filings Classification · 95% confidence The document is a press release ("Communiqué de presse") announcing that the company Intrasense won the first prize in the Covid-19 category at the 2021 e-health Trophies. This is an announcement about an award received, not a mandatory regulatory filing like a 10-K, an earnings release (ER), or a detailed financial report (IR). Since it is a general corporate announcement that doesn't fit the specific categories like AGM-R, 10-K, ER, or DIV, the most appropriate classification is the general regulatory/corporate announcement fallback category, RNS (Regulatory Filings), as it serves as a public disclosure of a significant, non-financial event. Given the short length and nature (press release), it is not a detailed report, but an announcement. RNS is the best fit among the options for a general corporate news release.
2021-09-27 French
Résultats semestriels 2021 : croissance continue et régulière sur 7 semestres consécutifs
Interim / Quarterly Report Classification · 95% confidence The document is a press release titled 'Résultats semestriels 2021' (2021 Half-Year Results) from Intrasense. It provides a summary of financial performance, including key aggregates, income statements, and balance sheet data for the first half of 2021. While it mentions that the full financial report will be published later, the document itself contains substantive financial data and analysis, qualifying it as an Interim/Quarterly Report (IR) rather than just a publication announcement. H2 2021
2021-09-22 French
2021 half-year results: continuous and regular growth over 7 consecutive semesters
Interim / Quarterly Report Classification · 95% confidence The document is a press release announcing the 2021 half-year financial results for Intrasense. It contains detailed financial tables, including a consolidated simplified half-year income statement and balance sheet aggregates, along with management's analysis of the performance. While it mentions that the full financial report will be published later, the document itself provides substantive financial data and analysis for the interim period, qualifying it as an Interim/Quarterly Report (IR) rather than just a publication announcement. H1 2021
2021-09-22 English
Intrasense participe au congrès de la SIFEM 2021 du 17 au 19 septembre
Regulatory Filings Classification · 95% confidence The document is a press release ("Communiqué de presse") dated September 14, 2021, announcing that the company Intrasense will participate in the SIFEM 2021 congress. It details the event, the company's focus (mammography, tomosynthesis, breast MRI solutions), and provides company background and contact information. This is not a formal regulatory filing like a 10-K, an earnings release (ER), or a detailed financial report (IR). It is an announcement about company activity, specifically related to industry events and product promotion, which fits best under the general category for miscellaneous regulatory/corporate announcements that don't fit specific financial reporting codes. Given the options, 'Regulatory Filings' (RNS) serves as the best fallback for general corporate news releases that aren't explicitly covered by other codes like DIV, CAP, or ER.
2021-09-14 French
Intrasense participates in the SIFEM 2021 congress from September 17 to 19
Regulatory Filings Classification · 95% confidence The document is a short press release announcing the company's participation in an upcoming industry congress (SIFEM 2021). It details the event, the company's focus (medical imaging solutions for breast cancer), and the specific products to be presented. Since this is an announcement about participation in an event, and not a formal regulatory filing like a 10-K, ER, or IR, it fits best under the general category for non-standard regulatory or corporate announcements. Given the options, 'Regulatory Filings' (RNS) serves as the best fallback for general corporate news releases that don't fit specific financial reporting codes (like ER, IR, DIV, etc.). It is not a Call Transcript (CT), Investor Presentation (IP), or a formal report (AR, 10-K).
2021-09-14 English
Intrasense fait le point sur sa stratégie de développement et ses perspectives de croissance
Report Publication Announcement Classification · 95% confidence The document is a press release dated September 7, 2021, detailing Intrasense's development strategy following a successful capital increase and announcing future plans, including the launch of a new oncology product line (Myra) and updates to the existing radiology line (Myrian). Crucially, the document contains the following statement near the end: "Intrasense publiera ses résultats semestriels 2021 le 22 septembre avant ouverture des marchés. La société invite ses actionnaires à participer au webinaire organisé le 22 septembre à 18h..." (Intrasense will publish its 2021 half-year results on September 22nd before market opening. The company invites its shareholders to participate in the webinar organized on September 22nd at 6 PM...). This structure—a strategic update combined with an explicit announcement of a future financial report publication (half-year results) and an invitation to a related event—strongly suggests this document is an announcement about the upcoming release of financial results, rather than the results themselves (which would be an IR) or a general regulatory filing (RNS). However, the primary content is strategic updates and capital structure context, not just the announcement of the results publication date. The document discusses strategy, capital increase follow-up, and governance changes (Extraordinary General Meeting resolutions). Given the explicit announcement of the publication of 'résultats semestriels 2021' (half-year results) and the invitation to a subsequent webinar, this fits the description of an Earnings Release (ER) or a Report Publication Announcement (RPA). Since it is a press release detailing strategic context *and* announcing the upcoming release of the full interim report, it functions most closely as an Earnings Release (ER) which often precedes the full Interim Report (IR) or as a general announcement. Comparing ER (initial announcement of key highlights) vs RPA (announcement regarding the timing/release of a report): This document provides strategic context and mentions the upcoming results publication date. It is not the full interim report (IR). It is more than just announcing the publication time (RPA); it contains substantive business updates. If the document were solely focused on the upcoming release date, RPA would be appropriate. Since it details strategy and mentions the upcoming results, ER is a strong candidate, as ERs often precede the full IR filing. However, the document is a 'Communiqué de presse' detailing strategy and *announcing* the date of the 'résultats semestriels 2021'. This is a classic function of an Earnings Release (ER) which provides the initial highlights/context before the full report (IR) is filed. I will classify it as an Earnings Release (ER) because it is a press release detailing business updates and setting the stage for the upcoming financial results release.
2021-09-07 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.